<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>12</Volume><Issue>12</Issue><PubDate PubStatus="epublish"><Year>2022</Year><Month>01</Month><Day>17</Day></PubDate></Journal><title locale="en_US">New COVID‑19 Variant, VUI‑202012/01: Molecular Change, Epitope  Alteration, and Implication for Vaccine Efficacy</title><FirstPage>2585</FirstPage><LastPage>2585</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Department of Community Medicine, Private Academic Consultant, Bangkok</affiliation></Author><Author><affiliation locale="en_US">1 Honoary Professor, Dr. D. Y. Patil University, Pune</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2022</Year><Month>01</Month><Day>17</Day></PubDate></History><abstract locale="en_US">&lt;p&gt;Dear Editor,&lt;/p&gt;&lt;p&gt;COVID‑19 is the new emerging coronavirus infection. The pandemic results in more than 75,000,000 people around the world (data on December 21, 2020). In clinical genetic, impact of genetic change on the infection is an interesting issue. The mutation might occur with the SARSCoV2 virus molecule.&lt;/p&gt;</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/2585</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/2585/717718425</pdf_url></Article></Articles>
